IPO-bound SAI Parenterals (SPL) has acquired a 74.6% controlling stake in Noumed Pharmaceuticals, an Adelaide-based pharmaceutical supplier, for Rs 125 crore. Noumed Pharmaceuticals, with reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results